Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Condition:   Uveal Melanoma Interventions:   Drug: ADI PEG20;   Drug: Nivolumab;   Drug: Ipilimumab Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials